.png)
Between the result produced by the analyzer and the payment deposited by the insurer, a laboratory test crosses two completely distinct chains: the clinical and the financial. The clinical chain has decades of investment behind it in analytical quality, accreditation, and traceability. The financial chain, in most Brazilian laboratories, still depends on manual mappings, outdated tables, and audit teams functioning as human filters for inconsistencies that technology should eliminate automatically. The point where these two chains meet, or fail to meet, is where billing denials happen.
Sector estimates indicate that losses from inconsistencies in the integration between laboratory data and billing systems represent 3% to 8% of gross revenue in hospital laboratories.¹ Not from tests that weren't performed. Not from fraud. But from semantic divergences between the data recorded in the Laboratory Information System (LIS) and the code transmitted in the TISS file to the insurer: an infrastructure failure that repeats automatically, every billing cycle, as long as the cause goes untreated at the layer where it actually originates: the data.
The anatomy of a laboratory billing denial
Brazil's Supplementary Health Information Exchange (TISS), the regulatory standard established by the National Supplementary Health Agency (ANS) for electronic information transmission between providers and insurers, requires that each procedure performed be identified by a precise code from the applicable procedure table. The problem begins before transmission: at the moment a test is registered in the LIS with a local nomenclature, such as "Fasting Glucose", "Plasma Glucose", or "GLU F", that nomenclature must be converted, manually or automatically, into the corresponding TISS code. When this conversion is done inconsistently, whether due to incomplete mapping, a table update not propagated across all systems, or nomenclature variations between departments, the TISS file sent to the insurer carries a code that doesn't match the procedure recorded in the clinical documentation. The result is predictable: a technical denial, with or without appeal rights depending on the contract in force.
The problem is structural. Laboratories that have grown through acquisitions, that operate multiple LIS simultaneously, or that have undergone system upgrades without complete migration of mapping tables accumulate inconsistencies that multiply proportionally to test volume. In an operation processing 50,000 tests per month, an inconsistency rate of 5% represents 2,500 procedures at risk of denial. That figure, multiplied by average procedure value and twelve months, produces a revenue impact that is rarely measured with that level of precision.
The cost that doesn't appear in the right report
A billing denial has a direct cost: revenue that doesn't arrive, or arrives late. It also carries an indirect cost that is rarely tracked alongside it. Each denial opens a cycle of error identification, documentation retrieval, appeal preparation, on-time submission, and outcome tracking. The higher the denial rate, the larger the team dedicated to that cycle and the less capacity that team has to direct its work toward indicator analysis and billing process improvement. Add to this the fact that 49% of professionals involved in billing and coding processes spend their time on manual data categorization and verification tasks.³ When laboratory data arrives at the billing system without prior harmonization, this team functions as a manual coding integrator: verifying whether the LIS nomenclature maps to the correct TISS code, whether table updates have been propagated, whether the department that performed the test used the same code as the department that ordered it. This rework is not an isolated deviation. It is the predictable consequence of an architecture in which clinical and financial data live in systems that don't speak the same language.
The root cause: LIS and billing with distinct vocabularies
The Laboratory Information System was designed to record, manage, and transmit test results. It optimizes the analytical operation: tracks samples, records values, issues reports. The billing system was designed to code procedures, verify eligibility, generate billing files, and track payments. They operate with distinct logic, distinct vocabularies, and distinct objectives. Integrating these two worlds requires an intermediate layer that translates the clinical data produced by the LIS, with its local nomenclature, spelling variations, and accumulated historical inconsistencies, into structured, semantically coherent data mapped to the codes required by billing systems and TISS rules. Without that layer, integration is only technical: the systems connect, but the data flowing between them is not equivalent.
The problem worsens in networks operating multiple units with different LIS systems or different versions of mapping tables. A test that appears as "Complete Blood Count" in one unit may be recorded as "CBC" in another and as "Hematology panel, red series, white series, and platelets" in a third. For the clinical analyst, all three are equivalent. For the billing system that must map each denomination to a specific TISS code, the equivalence must be declared explicitly and, when done manually or incompletely, becomes the primary source of the inconsistencies that generate denials.
Laboratories with predominantly unstructured systems show non-conformity rates 3.2 times higher than those with fully structured and integrated systems, along with non-conformity resolution times 48% longer.⁴ In the billing context, non-conformity translates directly into denial or payment delay.
What harmonized data changes in the billing cycle
When laboratory data is harmonized, with each test carrying a consistent semantic identification mapped to the standards recognized by insurers and the regulatory system, the flow between clinical production and financial billing no longer depends on error-prone manual conversions. The code sent in the TISS file is derived directly from the test recorded in the LIS, with verified and traceable equivalence.
The effects on the billing cycle are measurable. Hospitals that integrated laboratory data with the billing system through structured platforms **reduced billing denial rates by 41% and increased net laboratory revenue by 12% in the first year of integrated system operation.**⁵ The mechanism is direct: less semantic inconsistency means less divergence between clinical and financial data, which means less technical grounds for denial.
Beyond denial reduction, harmonization enables two additional operational gains with direct bottom-line impact: automated duplicate test verification, which allows duplicate billing to be identified and blocked before submission to the insurer, and the ability to generate prospective audit reports that identify inconsistency patterns before they materialize into denials. Rather than reacting to denials after the fact, management monitors risk vectors in real time.
The denial as symptom, not problem
The most common response to a high denial rate is to intensify internal auditing: reviewing each claim before submission, creating coding checklists, training the billing team. These measures reduce the symptom but don't eliminate the cause. As long as the data arriving at the billing system comes from a LIS with inconsistent nomenclatures, the audit team will continue functioning as a human filter for an infrastructure failure. The solution lies one layer up: ensuring that laboratory data, from its origin at the analyzer to its representation in the billing system, is semantically consistent, traceable, and mapped to the standards that insurers require. This is not a billing project. It's a data project.
This is precisely where OpenHealth Technologies operates. The platform automatically correlates multiple data streams with rigorously validated logical layers of laboratory tests, ensuring that each laboratory result carries a consistent, traceable semantic identification compatible with the interoperability standards required by the supplementary health ecosystem. For laboratories and hospitals, this means the information feeding the billing system is the same as what was produced clinically: without manual conversions, without partial mappings, without the silent accumulation of inconsistencies that become lost revenue.
Learn how your institution can transform integrated laboratory data into more efficient billing and fewer denials.